In type 1 diabetes, the immune system has learned to attack islet cells in the pancreas and relentlessly destroy them. New ...

UCSF research led to the first type 1 diabetes immunotherapy. Now, scientists are using stem cells and Tregs to find a ...

SAB Biotherapeutics’ SAB-142 targets stage 2/3 type 1 diabetes, aiming to preserve beta-cell function. Click here to read my ...

The global cell therapy manufacturing market is on track to nearly double, from $7.17 billion in 2026 to over $14 billion by ...

Building on validated HIP technology, Sana Biotechnology is advancing SC451, a stem cell-derived therapy designed as a one-time treatment targeting normal blood glucose without exogenous insulin or ...

Multiple Americans have been cured of their diabetes after a groundbreaking trial that has let them put down their insulin for good, researchers have announced.

Antibody therapeutics are laboratory-made proteins designed to work like the body's natural antibodies. They are widely used ...

David Novak and his late wife Wendy — who died from Type 1 diabetes complications in 2024 — spent their lives advocating for ...

Study in mice suggests that B cells help regulate muscle performance. Immune cells that help to fight off foreign invaders in ...

The immune system's B cells create antibodies that can mount a response against just about anything—either destroying a ...

Since Eledon Pharmaceuticals Inc.’s Phase 2 kidney trial failed to meet its primary endpoint, sending shares down nearly 50%, the Irvine-based biotech company is making progress in its other areas of ...